Clinical trial
Randomed and Double-blinded Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic Hepatitis
NCT02499562 is registered in ClinicalTrials.gov with Shanghai Genomics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomed and Double-blinded Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic Hepatitis
- Lead sponsor
- Shanghai Genomics, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 25, 2015
- Completion date
- November 20, 2020
- Enrollment
- 168 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.